BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
41 results:

  • 1. pou5f1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6.
    Yang W; Cui X; Sun D; Sun G; Yan Z; Wei M; Wang Z; Yu W
    Cell Death Dis; 2023 Dec; 14(12):802. PubMed ID: 38062041
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological Features of Non-Small Cell lung Carcinoma with BRAF Mutation.
    Ambrosini-Spaltro A; Rengucci C; Capelli L; Chiadini E; Calistri D; Bennati C; Cravero P; Limarzi F; Nosseir S; Panzacchi R; Valli M; Ulivi P; Rossi G
    Curr Oncol; 2023 Nov; 30(11):10019-10032. PubMed ID: 37999148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1.
    Chen J; Wu Z; Deng W; Tang M; Wu L; Lin N; Chen L; Fu Y; Zhao M; Chen C; Li W
    J Transl Med; 2023 Jul; 21(1):453. PubMed ID: 37422632
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
    Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
    J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
    Wang J; Shao F; Yang Y; Wang W; Yang X; Li R; Cheng H; Sun S; Feng X; Gao Y; He J; Lu Z
    Cancer Commun (Lond); 2022 Oct; 42(10):1008-1027. PubMed ID: 35975322
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Metabolomics analysis reveals oct4 overexpression drives metabolic reprogramming and enhanced glycolysis and pentose phosphate pathway in lung adenocarcinoma cells.
    Tang Y; Zhu L; Chen H; Meng S
    Biomed Chromatogr; 2022 Jun; 36(6):e5367. PubMed ID: 35274324
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway.
    Zheng Y; You H; Duan J; Chen B; Wu C; Chen P; Wang M
    Genes Genomics; 2022 Sep; 44(9):1039-1049. PubMed ID: 35150399
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Pro-Survival oct4/Stat1/Mcl-1 Axis Is Associated with Poor prognosis in lung Adenocarcinoma Patients.
    Su YC; Chen YC; Tseng YL; Shieh GS; Wu P; Shiau AL; Wu CL
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685622
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.
    Sánchez-Botet A; Quandt E; Masip N; Escribá R; Novellasdemunt L; Gasa L; Li VSW; Raya Á; Clotet J; Ribeiro MPC
    Cell Oncol (Dordr); 2021 Dec; 44(6):1273-1286. PubMed ID: 34604945
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
    Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
    J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating oct4 expression via m6A RNA methylation.
    Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
    Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Involvement of collagen XVII in pluripotency gene expression and metabolic reprogramming of lung cancer stem cells.
    Hsu HS; Liu CC; Lin JH; Hsu TW; Hsu JW; Li AF; Hung SC
    J Biomed Sci; 2020 Jan; 27(1):5. PubMed ID: 31928533
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]    [Full Text] [Related]  

  • 14. ASB6 Promotes the Stemness Properties and Sustains Metastatic Potential of Oral Squamous Cell Carcinoma Cells by Attenuating ER Stress.
    Hung KF; Liao PC; Chen CK; Chiu YT; Cheng DH; Kawasumi M; Kao SY; Lo JF
    Int J Biol Sci; 2019; 15(5):1080-1090. PubMed ID: 31182927
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors.
    Lee GJ; Lee H; Woo IS; Kim T; An HJ; Choi HJ; Lee YS; Lee KY; Lee J; Kang JH
    Lung Cancer; 2019 Jun; 132():9-16. PubMed ID: 31097100
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
    Jiang X; Liu F; Wang Y; Gao J
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Prognostic and Clinicopathologic Characteristics of oct4 and lung cancer: A Meta-Analysis.
    Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
    Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting of lung cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.
    Udoh K; Parte S; Carter K; Mack A; Kakar SS
    Stem Cell Rev Rep; 2019 Aug; 15(4):601-611. PubMed ID: 30835047
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness.
    Cho SH; Kuo IY; Lu PF; Tzeng HT; Lai WW; Su WC; Wang YC
    Cell Death Dis; 2018 Aug; 9(9):868. PubMed ID: 30158579
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
    Lai JZ; Lai HH; Cao D
    Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.